Purpose of the Procedure
- Differentiating between benign and malignant ovarian masses.
- Early detection of epithelial ovarian cancer.
- Monitoring treatment response and recurrence.
Book HE4 Ovarian Cancer Test | Lahalak Medical Platform
A precise screening tool for early ovarian cancer detection. HE4 offers higher sensitivity than CA-125 and helps differentiate between benign and malignant masses, ensuring accurate diagnostic outcomes.
Scientific name: Human Epididymis Protein 4 (HE4) Assay
A laboratory test measuring HE4 protein levels in the blood. It evaluates pelvic masses and monitors epithelial ovarian cancer, providing superior accuracy in distinguishing malignancies from benign conditions.
Service type
Laboratory test
Duration
10-15 minutes
Fasting
Fasting is not required
Included Services
- Blood sample collection
- Laboratory HE4 protein analysis
- Official results report
Medical Service Information
Why Choose HE4?
- Higher sensitivity in early stages compared to CA-125.
- Lower false-positive rates in benign conditions like endometriosis.
- Enhanced diagnostic accuracy when used in the ROMA algorithm.
Target Groups
- Women presenting with pelvic masses.
- Patients previously diagnosed for monitoring purposes.
- High-risk pregnancy cases requiring specialized monitoring.
Conditions & Notices
- Inform the lab about any current medications
Medical services you might also like
